{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:19:14Z","timestamp":1792819154553,"version":"4.5.0"},"reference-count":56,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007350","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007350","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PAICYT, UANL"},{"name":"SATT-Lutech"},{"name":"Kayvisa\/Kaybiotix\/-Pharma"},{"name":"ECOSNORD"},{"name":"ECOSNORD"},{"name":"SU\/LBM\/DRUG Lab\/Kaybiotix"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/2162402x.2022.2054305","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T13:10:36Z","timestamp":1649077836000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":38,"title":["PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells"],"prefix":"10.1080","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-6166","authenticated-orcid":false,"given":"Kenny Misael","family":"Calvillo-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["Mexico"]},{"name":"PSL University, CNRS, Laboratoire des Biomol\u00e9cules, LBM","place":["Paris, France"]},{"name":"PSL University, CNRS, Laboratoire des Biomol\u00e9cules, DRUG Lab, Site OncoDesign","place":["Les Ulis, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Mendoza-Reveles","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"G\u00f3mez-Morales","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["Mexico"]},{"name":"PSL University, CNRS, Laboratoire des Biomol\u00e9cules, LBM","place":["Paris, France"]},{"name":"PSL University, CNRS, Laboratoire des Biomol\u00e9cules, DRUG Lab, Site OncoDesign","place":["Les Ulis, France"]},{"name":"Kaybiotix, GmbH","place":["Baar, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashanti Concepci\u00f3n","family":"Uscanga-Palomeque","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-6474","authenticated-orcid":false,"given":"Philippe","family":"Karoyan","sequence":"additional","affiliation":[{"name":"PSL University, CNRS, Laboratoire des Biomol\u00e9cules, LBM","place":["Paris, France"]},{"name":"PSL University, CNRS, Laboratoire des Biomol\u00e9cules, DRUG Lab, Site OncoDesign","place":["Les Ulis, France"]},{"name":"Kaybiotix, GmbH","place":["Baar, Switzerland"]},{"name":"Kayvisa, AG","place":["Zug, Switzerland"]},{"name":"\u03c7-Pharma","place":["Les Ulis, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6183-0089","authenticated-orcid":false,"given":"Ana Carolina","family":"Mart\u00ednez-Torres","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodr\u00edguez-Padilla","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["Mexico"]},{"name":"LONGEVEDEN SA de CV","place":["Monterrey, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0240-7"},{"key":"e_1_3_7_4_1","first-page":"1067","volume-title":"Drug resistance to targeted therapies: d\u00e9j\u00e0 vu all over again [Internet]","author":"Groenendijk FH","year":"2014","unstructured":"Groenendijk FH, Bernards R. Drug resistance to targeted therapies: d\u00e9j\u00e0 vu all over again [Internet]. Vol. 8:Molecular Oncology. Elsevier. 2014. cited 2020 Jul 15 1067\u20131083. Available from: https:\/\/febs.onlinelibrary.wiley.com\/doi\/full\/10.1016\/j.molonc.2014.05.004"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0413-z"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1386829"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.107"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100008"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0165-6"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001796"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00781"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13885"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00024"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001796"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9852361"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im2002s39"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1523"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.497"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8885-3_21"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5949-x"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5394"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37924"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030561"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2618-7"},{"key":"e_1_3_7_26_1","unstructured":"Peng GL Li L Guo YW Yu P Yin XJ Wang S Liu CP. CD8+ cytotoxic and FoxP3+ regulatory T lymphocytes serve as prognostic factors in breast cancer. Am J Transl Res. 2019 Aug 15;11(8):5039\u20135053. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6731430\/"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu450"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.12.005"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1387\/ijdb.150061pa"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00588"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201908961"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X20191703449"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01256-y"},{"key":"e_1_3_7_36_1","first-page":"438","article-title":"Semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity","volume":"4","author":"Dudek AM","unstructured":"Dudek AM, Martin S, Garg AD, Agostinis PI. Semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. Internet]. 2013 Dec 11 [cited 2018 Dec 21];4:438. Available from:. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24376443.","journal-title":"Front Immunol"},{"key":"e_1_3_7_37_1","article-title":"Immunogenic apoptosis as a novel tool for anticancer vaccine development [Internet]","volume":"19","author":"Montico B","year":"2018","unstructured":"Montico B, Nigro A, Casolaro V, Dal Col J. Immunogenic apoptosis as a novel tool for anticancer vaccine development [Internet]. International Journal of Molecular Sciences MDPI AG. 2018 [cited 2021 Jun 22]. Available from; 19. \/pmc\/articles\/PMC5855816\/.","journal-title":"International Journal of Molecular Sciences MDPI AG"},{"issue":"1","key":"e_1_3_7_38_1","first-page":"529","article-title":"A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine","volume":"16","author":"Abdellateif MS","unstructured":"Abdellateif MS, Shaarawy SM, Kandeel EZ, El-Habashy AH, Salem ML, El-Houseini ME. A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine. Oncol Lett. 2018 Jul 1 Internet]. [cited 2022 Jan 27];16(1):529\u2013535. Available from: http:\/\/www.spandidos-publications.com\/1\u00a00.3892\/ol.2018.8631\/abstract.","journal-title":"Oncol Lett"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.955691"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b03218"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2241"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02570-y"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.08.011"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.356"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2014.04.002"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003477"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3020344"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318155a0f6"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.24.9149-9161.2000"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0923"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3151"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000028086"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0623-5"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14356"},{"key":"e_1_3_7_55_1","volume-title":"Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells [Internet]","author":"Calmeiro J","year":"2020","unstructured":"Calmeiro J, Carrascal MA, Tavares AR, Ferreira DA, Gomes C, Falc\u00e3o A, et al. Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells [Internet]. Vol. 12:Pharmaceutics. MDPI AG. 2020. [cited 2020 Jul 22]. Available from: \/pmc\/articles\/PMC7076373\/?report=abstract"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.04.01"},{"issue":"6","key":"e_1_3_7_57_1","first-page":"375","article-title":"Cancer immunotherapy, part 1: current strategies and agents","volume":"42","author":"Lee Ventola C","unstructured":"Lee Ventola C. Cancer immunotherapy, part 1: current strategies and agents. P T. Internet]. 2017 Jun 1 [cited 2020 Jul 22];42(6):375\u2013383. Available from: \/pmc\/articles\/PMC5440098\/?report=abstract","journal-title":"P T"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2022.2054305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:29:25Z","timestamp":1742304565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2022.2054305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/2162402X.2022.2054305"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2022.2054305","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2054305"}}